Royalty Report: Drugs, Pain, Wound Care – Collection: 203328


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Pain
  • Wound Care
  • Pharmaceuticals
  • Medical
  • Therapeutic
  • Supply
  • Surgical
  • Delivery

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 203328

License Grant
Pursuant to this agreement, Licensor, an individual, has assigned his entire right, title and interest in, to and under the inventions described in the 925 application to Licensee.

Licensee is hereby granted and shall have a non-exclusive, perpetual, irrevocable, worldwide license to make, have made, modify, reproduce, display, use and sell such Item as part or in connection with such inventions.

Licensor grants to Licensee an exclusive option to obtain an exclusive, worldwide license to any Licensor Technology.

License Property
Licensor has assigned his entire right, title and interest in, to and under the inventions described in U.S. patent application. Serial No. 09/425,925 (the ''925 application'), entitled, 'Local Prevention or Amelioration of Pain from Surgically Closed Wounds,' which issued as U.S. Patent No. 6,383,511 (the ''511 Patent') to Cassel, as the inventor.

The term Licensors Technology means all copyrightable material, notes, records, inventions, improvements, developments, discoveries and trade secrets conceived, made by or discovered by Licensor outside of the performances of his services.

The Product means any composition of matter, material, device, apparatus, or system developed by Licensee for the treatment of pain from surgically closed wounds, which the making, using, offering for sale, sale or importation by an unlicensed third party, would infringe one or more issued claims of a Patent.

Field of Use
This agreement is for the field of surgical wound pain management.
LidoPAIN SP is a sterile prescription analgesic patch designed to provide sustained topical delivery of lidocaine to a post-surgical or post-traumatic sutured wound while also providing a sterile protective covering for the wound.

IPSCIO Record ID: 273277

License Grant
Licensor grants a royalty-bearing, exclusive right and license, with the right to grant sublicenses under the Licensor Intellectual Property and Licensor Product Registration Data to develop, market, use, sell, offer for sale and import the LidoPAIN® BP Product within the Territory and develop, make, have made, manufacture, market, use, sell, offer for sale and import the Licensee BP Product in the Territory.
License Property
Licensor is currently developing a topical lidocaine patch product currently known as LidoPAIN® BP.

Licensed Products means, collectively, the Licensee BP Product and the LidoPAIN® BP Product.

LidoPAIN® BP Product means a non-sterile adhesive backed topical patch, for sale by prescription only, containing lidocaine as the only active ingredient and indicated, and approved by the FDA, for the treatment of acute low back pain or a substantially similar indication.

Licensee BP Product means a non-sterile adhesive backed topical patch, for sale by prescription only, containing lidocaine as the only active ingredient.

Field of Use
The field of use is for the treatment of acute low back pain and owns patents covering the use of a topical lidocaine patch product for the treatment of low back pain.

IPSCIO Record ID: 4355

License Grant
The Licensor hereby grants to the Licensee, an exclusive, worldwide royalty-bearing, assignable, transferable, irrevocable License with the right to grant sublicenses of the Licensee Products, and to make or to have made for the Licensee’s use, import, or offer for sale, or any combination thereof, Licensee Products within the territory.
License Property
Licensed Technology means any intellectual property, invention, know-how, trade secrets, technical information, research and development information, test results, and data that comprise or form part of the certain invention concerning SilverlonOTC Wound Care

Licensed Patents
U.S. 7,230,153 C2
U.S. 7,291,762 B2
U.S. 7,989,674 B2
U.S. 8,093,444 B2
U.S. 8,118,791

Field of Use
The licensing agreement enables the Licensee to develop, market and sell OTC wound care products based on Silverlon’s proprietary silver coating technology, which provides superior performance for wound treatment. The technology, with its permanently plated metallic surface, reduces the occurrence of surgical site infections.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.